David C. Wright
General Contractor in Chapel Hill, NC

License number
North Carolina 25782
Renew Date
Jan 1, 2017
Category
General Contractor
Type
Building PU(Communications)
Address
Address
PO Box 3086, Chapel Hill, NC 27515
Phone
(919) 929-0134

Professional information

David Wright Photo 1

Shareholder At Robinson Bradshaw

Position:
Shareholder at Robinson, Bradshaw & Hinson
Location:
Charlotte, North Carolina Area
Industry:
Legal Services
Work:
Robinson, Bradshaw & Hinson since Sep 1984 - Shareholder United States Court of Appeals for the Fourth Circuit -- Hon. James Dickson Phillips, Jr. - Chapel Hill, NC 1983 - 1984 - Law Clerk
Education:
University of Virginia School of Law 1980 - 1983
J.D., Law
UNC Chapel Hill 1976 - 1980
Bachelor's degree w/ Highest Honors, English
Skills:
Commercial Litigation, Civil Litigation, Litigation, Trial Practice, Class Actions, Legal Writing, Product Liability, Mergers, Arbitration, Mediation, Legal Research, Personal Injury, Intellectual Property, Toxic Tort, Westlaw
Interests:
I enjoy playing golf just about anywere and I follow the San Francisco Ballet (my daughter is a soloist). Go Panthers and Tarheels!
Awards:
Professional Distinctions
Woodward/White, Inc., The Best Lawyers in America, bet-the-company litigation, commercial litigation, employment law - management, labor law - management, product liability litigation-defendants, 2006-13 Chambers USA: America’s Leading Lawyers for Business, litigation, 2012 North Carolina Super Lawyers, Top 100 North Carolina Super Lawyer, business litigation, 2009-13. Top 25 Lawyers in Charlotte -- 2013. Business North Carolina, Legal Elite, employment, 2006-07; litigation, 2010-12 Benchmark Litigation, North Carolina leading litigation attorney Martindale-Hubbell, AV® Preeminent™ Peer Review Rated


David Wright Photo 2

Senior Regulatory Affairs Professional

Position:
Director, Regulatory Affairs at Ockham Oncology
Location:
Chapel Hill, North Carolina
Industry:
Pharmaceuticals
Work:
Ockham Oncology - Cary, NC - Director, Regulatory Affairs Tranzyme Pharma - Durham, NC 2012 - 2013 - Senior Director, Regulatory Affairs BioDelivery Sciences International - Raleigh, NC 2007 - 2011 - Vice President, Regulatory Affairs Adherex Technologies - Durham, NC 2004 - 2007 - Director, Regulatory Affairs EMD Pharmaceuticals / Merck KGaA - Durham, NC 2002 - 2004 - Associate Director, Regulatory Affairs Glaxo Wellcome / GlaxoSmithKline - Durham, NC 1998 - 2002 - Project Director, Regulatory Affairs NJC Enterprises / Pharmakopius International - Durham, NC 1994 - 1998 - Manager, Regulatory Affairs
Education:
North Carolina State University 1992 - 1994
PhD, Toxicology and Cell Biology
University of North Carolina at Chapel Hill 1989 - 1992
MSc, Toxicology
University of Waterloo 1984 - 1988
BSc, Honours Applied Chemistry
Skills:
Regulatory Submissions, Regulatory Affairs, Regulatory Strategy, Drug Development, Clinical Development, Nonclinical Development, Toxicology, Chemistry, Oncology, eCTD, IND, CTA, NDA, MAA, REMS, Pharmaceutical Industry, Biotechnology Industry, Life Sciences, CRO, Protocol
Certifications:
Regulatory Affairs Certified (RAC), Regulatory Affairs Professionals Society


David Wright Photo 3

Methods For Detecting Single Nucleotide Polymorphisms

US Patent:
7223536, May 29, 2007
Filed:
Feb 7, 2001
Appl. No.:
09/778168
Inventors:
David J. Wright - Chapel Hill NC, US
Maria A. Milla - Wynnewood PA, US
James G. Nadeau - Chapel Hill NC, US
G. Terrance Walker - Chapel Hill NC, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 243
Abstract:
The present invention provides methods for detecting and identifying sequence variations in a nucleic acid sequence of interest using a detector primer. It has been found that the reduced efficiency of primer extension by DNA polymerases when the 3′ end of a primer does not hybridize perfectly with the target can be adapted for use as a means for distinguishing or identifying the nucleotide in the target which is at the site where the diagnostic mismatch between the detector primer and the target occurs. The detector primer hybridizes to the sequence of interest and is extended with polymerase. The efficiency of detector primer extension is detected as an indication of the presence and/or identity of the sequence variation in the target. The inventive methods make use of nucleotide mismatches at or near the 3′ end of the detector primer to discriminate between the nucleotide sequence of interest and a second nucleotide sequence which may occur at that same site in the target. The methods are particularly well suited for detecting and identifying single nucleotide differences between a target sequence of interest (e. g.


David Wright Photo 4

Methods And Oligonucleotides For Detecting Nucleic Acid Sequence Variations

US Patent:
2001003, Nov 8, 2001
Filed:
Feb 7, 2001
Appl. No.:
09/778175
Inventors:
David Wright - Chapel Hill NC, US
Maria Milla - Wynnewood PA, US
James Nadeau - Chapel Hill NC, US
G. Walker - Chapel Hill NC, US
International Classification:
C12P019/34, C07H021/04, C12Q001/68
US Classification:
536/023100, 435/006000, 435/091100
Abstract:
The present invention provides methods for detecting and identifying sequence variations in a nucleic acid sequence of interest using a detector primer. It has been found that the reduced efficiency of primer extension by DNA polymerases when the 3′ end of a primer does not hybridize perfectly with the target can be adapted for use as a means for distinguishing or identifying the nucleotide in the target which is at the site where the diagnostic mismatch between the detector primer and the target occurs. The detector primer hybridizes to the sequence of interest and is extended with polymerase. The efficiency of detector primer extension is detected as an indication of the presence and/or identity of the sequence variation in the target. The inventive methods make use of nucleotide mismatches at or near the 3′ end of the detector primer to discriminate between the nucleotide sequence of interest and a second nucleotide sequence which may occur at that same site in the target. The methods are particularly well suited for detecting and identifying single nucleotide differences between a target sequence of interest (e.g., a mutant allele of a gene) and a second nucleic acid sequence (e.g., a wild type allele for the same gene).


David Wright Photo 5

Methods And Oligonucleotides For Detecting Nucleic Acid Sequence Variations

US Patent:
2002002, Feb 28, 2002
Filed:
Jun 17, 1999
Appl. No.:
09/335218
Inventors:
DAVID J. WRIGHT - CHAPEL HILL NC, US
MARIA MILLA - WYNNEWOOD PA, US
JAMES G. NADEAU - CHAPEL HILL NC, US
G. TERRANCE WALKER - CHAPEL HILL NC, US
International Classification:
C12Q001/68, C07H021/04, C12P019/34
US Classification:
435/006000, 536/024300, 435/091200
Abstract:
The present invention provides methods for detecting and identifying sequence variations in a nucleic acid sequence of interest using a detector primer. It has been found that the reduced efficiency of primer extension by DNA polymerases when the 3′ end of a primer does not hybridize perfectly with the target can be adapted for use as a means for distinguishing or identifying the nucleotide in the target which is at the site where the diagnostic mismatch between the detector primer and the target occurs. The detector primer hybridizes to the sequence of interest and is extended with polymerase. The efficiency of detector primer extension is detected as an indication of the presence and/or identity of the sequence variation in the target. The inventive methods make use of nucleotide mismatches at or near the 3′ end of the detector primer to discriminate between the nucleotide sequence of interest and a second nucleotide sequence which may occur at that same site in the target. The methods are particularly well suited for detecting and identifying single nucleotide differences between a target sequence of interest (e.g., a mutant allele of a gene) and a second nucleic acid sequence (e.g., a wild type allele for the same gene).


David Wright Photo 6

Detection Of Mycobacteria By Multiplex Nucleic Acid Amplification

US Patent:
5811269, Sep 22, 1998
Filed:
Apr 30, 1996
Appl. No.:
8/640378
Inventors:
James G. Nadeau - Chapel Hill NC
Cheryl H. Dean - Raleigh NC
James L. Schram - Knightdale NC
Deborah R. Howard - Durham NC
Margaret S. Dey - Durham NC
David J. Wright - Chapel Hill NC
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12P 1934, C07H 2104
US Classification:
435 911
Abstract:
Primers and methods for adapter-mediated multiplex amplification of the IS6110 insertion element of the Mycobacterium tuberculosis (M. tb) complex and a 16S rDNA target common to essentially all mycobacteria are described. In certain embodiments, the primers are optimized for efficient multiplex amplification in thermophilic SDA. The multiplex Strand Displacement Amplification methods of the invention are capable, in a single amplification reaction, of simultaneously identifying M. tuberculosis and providing a screen for substantially all of the clinically relevant species of mycobacteria. Also disclosed are internal control sequences designed for coamplification with the two targets, allowing assessment of amplification efficiency and/or quantitation of the targets.


David Wright Photo 7

Strand Displacement Amplification Using Thermophilic Enzymes

US Patent:
5648211, Jul 15, 1997
Filed:
Apr 18, 1994
Appl. No.:
8/229279
Inventors:
Melinda S. Fraiser - Durham NC
Catherine A. Spargo - Cary NC
George Terrance Walker - Chapel Hill NC
Mark Van Cleve - San Jose CA
David James Wright - Chapel Hill NC
Michael C. Little - Baltimore MD
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 168, C12P 1934
US Classification:
435 6
Abstract:
Strand Displacement Amplification methods (thermophilic SDA) which can be performed over a broad temperature range (37. degree. C. to 70. degree. C. ). The preferred temperature range for thermophilic SDA is 50. degree. C. to 70. degree. C. It has been found that certain thermophilic restriction endonucleases are capable of nicking the hemimodified restriction endonuclease recognition/cleavage site as required by SDA and dissociating from the site. It has further been found that certain thermophilic polymerases are capable of extending from the nick while displacing the downstream strand. Thermophilic SDA, because of reaction temperatures higher than previously possible with conventional SDA enzyme systems, has improved specificity and efficiency, reduced nonspecific background amplification, and potentially improved yields of amplification products. In addition, the need to add the enzymes in a separate step after the initial heat denaturation of double stranded targets is eliminated when enzymes capable of tolerating the denaturation temperature are used.


David Wright Photo 8

Binding Protein As Biosensors

US Patent:
6855556, Feb 15, 2005
Filed:
Jan 4, 2002
Appl. No.:
10/040077
Inventors:
Terry J. Amiss - Cary NC, US
Colleen M. Nycz - Raleigh NC, US
J. Bruce Pitner - Durham NC, US
Douglas B. Sherman - Durham NC, US
David J. Wright - Chapel Hill NC, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G01N033/48
US Classification:
436 95, 438 86, 438164, 438172, 435 72, 435 14, 4352871, 435817
Abstract:
The invention is directed to compositions of mutated binding proteins containing reporter groups, analyte biosensor devices derived there from, and their use as analyte biosensor both in vitro and in vivo.